Anti-VEGF treatments: The past, present and future of AMD

Encouraging news from the National Eye Institute (NEI). A recent study of 647 AMD patients treated with anti-VEGF drugs for five years showed that half maintained 20/40 vision or better. The study’s authors heralded this as a huge achievement, which…